Many years have been spent trying to develop a drug that can prevent metastasis. Yet, up until now, cancer has remained a ...

MEDIA RELEASEFirst FDA-approved abbreviated new drug application (ANDA) to reference medicineSingle-dose 100 mg vial for intravenous use, ...

(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...

In today’s Health Alert, new research shows that an easy blood test could help doctors decide on the best way to treat ...

A recent phase 3 clinical trial has revealed a promising method that may significantly enhance how doctors predict survival ...

Lazcluze demonstrated significant CNS activity, regardless of T790M status, in treating intracranial and leptomeningeal ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which ...

The non-invasive test, which measures circulating tumor cells in the blood, can predict treatment response, disease ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...

For patients with metastatic colorectal cancer, adding a higher dose proves just as effective as the standard dose of vitamin D3, despite one exception.

CTCs are rare cancer cells that tumors shed in the blood. They've been looked at before in prostate cancer, but only in its ...

A phase 3 clinical trial shows that a blood test can predict response to treatment for metastatic prostate cancer.